Your position:www.healthoo.com >> EN >> EN >> Formulation >> Sodium thiosulfate has been approved by the FDA to reduce hearing loss in children caused by chemotherapySodium thiosulfate has been approved by the FDA to reduce hearing loss in children caused by chemotherapy >> article
 
Sodium thiosulfate has been approved by the FDA to reduce hearing loss in children caused by chemotherapySodium thiosulfate has been approved by the FDA to reduce hearing loss in children caused by chemotherapy
Editor:xuezhe    Clicks:0    Date:2022-10-20 10:34:48
Keyword: FDA
Healthoo Information:
Sodium thiosulfate has been approved by the FDA to reduce hearing loss in children caused by chemotherapy
 
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
　　Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Relative Information
  • FDA approves ibrutinib for chronic graft-versus-host disease in childr...
  • FDA Issues Drug Statement, Mercks Hypoglycemic Drug Sitagliptin Detect...
  • Upadatinibs launch accelerated: Crohns disease has simultaneously subm...
  • FDA Breakthrough Therapy Designation for Topical Vitamin A Derivatives...
  • AstraZenecas Ultomiris Third Indication Approved by US FDA!
  • New Drugs Approved by FDA in February 2022
  • Nature: FDA Approval of New Drugs Sales Forecast in 2021
  • FDA cautions Aurobindo oral solids formulation facility
  • Nhwa received FDA warning Letter for 3 APIs
  • Lihua received import alert from FDA
    • Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
    Tel:+86-10-68032463